(ACU7) Amundi Index Solutions - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU2059756598 • Europe Large-Cap Blend Equity
ACU7: Index Funds, Exchange Traded Funds, Sustainable Investments
Amundi Index Solutions - Amundi MSCI Europe SRI PAB UCITS ETF DR D (XETRA: ACU7) is a European large-cap blend equity ETF designed to track the performance of companies in developed Europe, incorporating ESG criteria. The fund is listed on XETRA, with a ticker symbol of ACU7, and is domiciled in Germany. It provides exposure to a market-capitalization-weighted index of large-cap companies in developed Europe, focusing on those that meet specific sustainability and ethical standards. The ETFs average daily trading volume over the past 20 days is 2,357 shares, with a last price of 68.76 EUR. The funds assets under management (AUM) stand at 127.73 million EUR, indicating moderate investor interest and liquidity. The ETFs technical indicators show a short-term SMA (20-day) of 69.69, a medium-term SMA (50-day) of 68.09, and a long-term SMA (200-day) of 67.36, suggesting a slightly bullish trend in recent weeks. The ATR (Average True Range) of 0.58 reflects relatively low volatility in the ETFs price movements.
Based on the provided
Additional Sources for ACU7 ETF
ACU7 ETF Overview
Market Cap in USD | 140m |
Category | Europe Large-Cap Blend Equity |
TER | 0.18% |
IPO / Inception | 2019-10-23 |
ACU7 ETF Ratings
Growth 5y | 18.2% |
Fundamental | - |
Dividend | 57.4% |
Rel. Strength | -5.2 |
Analysts | - |
Fair Price Momentum | 55.34 EUR |
Fair Price DCF | - |
ACU7 Dividends
Dividend Yield 12m | 2.31% |
Yield on Cost 5y | 2.39% |
Annual Growth 5y | 7.33% |
Payout Consistency | 98.3% |
ACU7 Growth Ratios
Growth Correlation 3m | -15.8% |
Growth Correlation 12m | 27.2% |
Growth Correlation 5y | 76.5% |
CAGR 5y | -0.77% |
CAGR/Max DD 5y | -0.03 |
Sharpe Ratio 12m | 0.24 |
Alpha | -8.58 |
Beta | 0.570 |
Volatility | 14.71% |
Current Volume | 4.8k |
Average Volume 20d | 2.1k |
As of April 08, 2025, the stock is trading at EUR 59.38 with a total of 4,795 shares traded.
Over the past week, the price has changed by -9.85%, over one month by -13.28%, over three months by -10.81% and over the past year by -8.12%.
Neither. Based on ValueRay Analyses, Amundi Index Solutions is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 18.24 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACU7 as of April 2025 is 55.34. This means that ACU7 is currently overvalued and has a potential downside of -6.8%.
Amundi Index Solutions has no consensus analysts rating.
According to ValueRays Forecast Model, ACU7 Amundi Index Solutions will be worth about 60.6 in April 2026. The stock is currently trading at 59.38. This means that the stock has a potential upside of +2.11%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 60.6 | 2.1% |